← Skin Intelligence Digest
Emergingclinical

We Tested Pimple Patches on Real Breakouts—These 9 Helped Flatten and Heal Overnight

Published June 12, 20261 min read
Intelligence brief

I remember the very first set of pimple patches I ordered on Amazon. I was so confused how a tiny clear sticker could get rid of acne . And admittedly, I was pretty disappointed at first. Everyone was saying that these patches could pop my pimples for me, or heal a breakout overnight. That, sadly, was never the case for me. But once I learned how to use them, the results I could actually expect, and the products that were really good, I became hooked. Why we love it: These extra large pimple patches are ideal for clusters of breakouts across the chin, forehead, or wherever else your acne tends to flare up. Each one has more than 1,000 microdarts that are loaded with ingredients like salicylic acid and niacinamide to precisely target the area. After a few hours, the micropoints dissolve, feeding your skin with acne-fighting ingredients. Jasmine Hyman is the Assistant Beauty Editor at Cosmopolitan , where she writes about the latest beauty trends and must-have products. Her most prized beauty possessions are a meticulous skincare routine and…

Key signals
  • Ingredient signal
    Coverage centres on niacinamide, pay attention to concentration, vehicle, and pairings in your routine before changing anything material.
  • Protocol implication
    If you actively address breakout, this is a data point worth logging, not a directive to change the protocol on its own.
Ingredients referenced
Relevant concerns
breakoutpimple
Related research in the vault
ingredientsRCT

Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.

J Peripher Nerv Syst · Mar 2026

Recent preclinical studies have shown that nicotinamide adenine dinucleotide (NAD+) plays a critical role in molecular mechanisms of axon degeneration, and reductions in NAD+ levels are associated with axonal degeneration. Nicotinamide riboside (NR) is a safe and widely available pyridine-nucleoside form of vitamin B3 and is an NAD+ precursor. To investigate if oral supplementation of synthetic NR can act as a therapeutic agent to prevent degeneration of small somatic sensory axons innervating the skin or promote regeneration of these same fibers in humans, we utilized a validated experimental model of cutaneous nerve degeneration and regeneration and conducted a placebo-controlled, double-blinded Phase 2 study.

niacinamidepharct
Read →
ingredientsRCT

Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.

Photochem Photobiol Sci · May 2026

Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear. To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation. In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days.

niacinamidepharosacea
Read →
ingredientsRCT

Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Lancet Neurol · May 2026

Friedreich's ataxia is a rare, chronic, progressive, neurodegenerative condition affecting multiple organ systems, including neurological, musculoskeletal, cardiac, and endocrine systems, and is marked by low cardiopulmonary fitness. We tested the effect of exercise and NAD+ precursor supplementation with nicotinamide riboside, which have each shown benefits in animal and early clinical studies, on cardiopulmonary fitness in individuals with Friedreich's ataxia. This 12-week, outpatient, phase 2, single-site (Children's Hospital of Philadelphia, Philadelphia, PA, USA), randomised, 2 × 2 factorial clinical trial recruited individuals aged 10-40 years with an ejection fraction of 45% or greater who were able to exercise.

niacinamidepharct
Read →

This intelligence brief synthesizes reporting from beauty and dermatology industry publications.

View source →

This information is for educational purposes only and is not medical advice. Individual results vary. Consult a qualified dermatologist or healthcare professional for medical concerns. Full disclaimer →